Tumor Imaging Using 1-(2'-deoxy-2'-18F- Fluoro-ß-D-Arabinofuranosyl)Thymine and PET
Omid S. Tehrani1,2,
Otto Muzik1,3,
Lance K. Heilbrun1,
Kirk A. Douglas1,2,
Jawana M. Lawhorn-Crews1,2,
Haihao Sun1,
Thomas J. Mangner1,4 and
Anthony F. Shields1,2
1 Karmanos Cancer Institute, Wayne State University, Detroit, Michigan; 2 Department of Medicine, Wayne State University, Detroit, Michigan; 3 Department of Pediatrics, Wayne State University, Detroit, Michigan; and 4 Department of Radiology, Wayne State University, Detroit, Michigan

View larger version (10K):
[in this window]
[in a new window]
|
FIGURE 1. Scatter plots of tumor SUV at 50–60 min images compared with 5–11 min images. (A) SUVmean. (B) SUVmax. Solid line represents linear regression model. Dashed lines represent 90% confidence limits for predicted mean value of SUV from 50–60 min images for a given value of SUV from 5–11 min images.
|
|

View larger version (10K):
[in this window]
[in a new window]
|
FIGURE 3. Plasma analysis HPLC chromatogram depicts activity of each 30-s fraction. Sample is collected at 11 min after injection.
|
|

View larger version (10K):
[in this window]
[in a new window]
|
FIGURE 4. Scatter plots comparing TRR and 3-compartment flux. (A) TRR from 11 min images, simplified method using blood vs. flux. (B) TRR from 11 min images using muscle vs. flux. Solid line represents linear regression model. Dashed lines represent 90% confidence limits for predicted mean TRR for a given level of flux.
|
|
Copyright © 2007 by the Society of Nuclear Medicine.